Clinical Trial

The Safety And Efficacy Of A Probiotic Intervention On Lactulose Hydrogen Breath Test-Positive Patients And Related Gastrointestinal Symptoms

Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to test the effect of a probiotic formulation on gastrointestinal symptoms, gut and small intestine microbiota in participants suffering from small intestinal bacterial overgrowth (SIBO). Two doses of probiotic will be evaluated against placebo.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2024-03-11; most recent amendment 2025-04-24.
Status change: Not Yet Recruiting → Recruiting 2024-07-30
Trial Details
NCT Number NCT06317441
Lead Sponsor Nimble Science Ltd.
Collaborators: Lallemand Health Solutions
Conditions Small Intestinal Bacterial Overgrowth, SIBO
Enrollment 105 participants
Start Date 2024-07-20
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-04-29